University of California San Francisco
Displaying 10411 - 10440 of 16515
-
-
Can a Doughnut be a Drug?
-
A Gene for Lou Gehrig's Disease and Frontotemporal Dementia Identified
Frontotemporal dementia and amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease -- two fatal neurodegenerative disease with distinct symptoms -- are triggered by a common mutation in many cases, according to researchers who say they have identified the mutated gene.
-
Porsche Race Car Classic
-
International Surgeons Learn Life-Changing Procedures from UCSF/SFGH Surgeons
<p>UCSF surgeons at the Institute for Global Orthopaedics & Traumatology hosted a symposium designed to provide hands-on training in trauma care to physicians from around the world.</p>
-
2 from Bay Area Among MacArthur Fellows
-
UCSF School of Nursing Rallies for the Future
<p>For two days, the UCSF School of Nursing faculty and staff pondered its long term future, sketching the beginnings of an ambitious blueprint to guide the nursing program over the next five years.</p>
-
Forbes 400 Biggest Gifts
-
Salesforce's Marc Benioff: Use the Power of Your Company for Philanthropy
-
UCSF Neurologist William Seeley Named MacArthur Fellow
<p>UCSF neurologist William Seeley, MD, has been named a 2011 MacArthur Fellow, one of the highest honors bestowed on an individual in the United States.</p>
-
Whooping Cough Vaccine's Durability Questioned
-
UCSF Competes Successfully for Young Innovator Awards
<p>Three UCSF researchers have been named among the 2011 recipients of the National Institutes of Health (NIH) Director's New Innovator Awards, one of the most competitively sought-after sources of research funding made available to young academic scientists through the NIH.</p>
-
MacArthur Foundation Selects 22 'Geniuses'
-
ABC7 Talks to Bay Area "Genius Grant" Recipients
-
Need Help with Health? There's an App for That
-
UCSF Prof. Wins MacArthur Grant, Becomes Father on Same Day
-
The War on Cancer Continues
-
UCSF Study Identifies Weakness in Heart Attack Therapy
A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.
-
UCSF Neurologist, Marin County Poet Among MacArthur Grant Winners
-
Lipo at the Bridal Show: When Did Bridal Shows Get so Crazy?
-
CTSI Research Award Helps Move Promise to Product at UCSF
<p>Faculty are encouraged to apply for the <a href="https://innovation.ucsf.edu/venture/catalyst-program">T1 Translational Catalyst Award</a>, which is designed to help drive promising, early-stage research through the lengthy and complex process of bringing products and procedures to patients.</p>
-
Hiring Homeless Key to City's Plan
-
Life after Cancer and Preserving Fertility for the Future
-
LISA MAYORGA: Thankful for Early Warning
-
Ob-Gyn Guidelines Often Based on Opinion, Weak Data
-
UC Regents Endorse Tobacco Tax for Cancer Research
-
Final Day of Wounded Warrior Conference Focuses on Survivor Guilt
-
Final Five Go to the Polls in QB3 Science Contest
-
C-section Not Necessarily End to Vaginal Delivery
-
Link Between Racial Discrimination and Stress Described in New Study